INTELLIA THERAPEUTICS, INC. Earnings Per Share (Basic)
INTELLIA THERAPEUTICS, INC. (NTLA) reported Earnings Per Share (Basic) of -$0.80 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- INTELLIA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.80.
- INTELLIA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.81.
- INTELLIA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.83.
- INTELLIA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.92.
- INTELLIA THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$3.81.
- INTELLIA THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$5.25.
- INTELLIA THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$5.42.
- INTELLIA THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$6.16.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.80 10-Q · filed 2026-08-06 | -$1.61 10-Q · filed 2026-08-06 | -$2.43 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.35 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2026-03-31 | -$0.81 10-Q · filed 2026-05-11 | -$1.64 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.55 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.52 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-12-31 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$1.74 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$2.71 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.81 10-K · filed 2026-02-26 |
| 2025-09-30 | -$0.92 10-Q · filed 2025-11-06 | -$1.89 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.99 10-Q · filed 2025-11-06 | -$4.25 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | -$0.98 10-Q · filed 2026-08-06 | -$2.08 10-Q · filed 2026-08-06 | -$3.34 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$4.68 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | -$1.10 10-Q · filed 2026-05-11 | -$2.37 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.71 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$5.22 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2024-12-31 | -$1.27 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$2.61 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$4.12 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$5.25 10-K · filed 2026-02-26 |
| 2024-09-30 | -$1.34 10-Q · filed 2025-11-06 | -$2.86 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$3.99 10-Q · filed 2025-11-06 | -$5.44 derived: net income ÷ weighted average shares · filed 2026-04-30 |
| 2024-06-30 | -$1.52 10-Q · filed 2025-08-07 | -$2.64 10-Q · filed 2025-08-07 | -$4.10 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$5.48 derived: net income ÷ weighted average shares · filed 2026-04-30 |
| 2024-03-31 | -$1.12 10-Q · filed 2025-05-08 | -$2.58 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$3.95 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$5.35 derived: net income ÷ weighted average shares · filed 2026-04-30 |
| 2023-12-31 | -$1.46 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$2.84 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$4.24 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$5.42 10-K · filed 2026-02-26 |
| 2023-09-30 | -$1.38 10-Q · filed 2024-11-07 | -$2.78 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$3.96 10-Q · filed 2024-11-07 | -$5.35 derived: net income ÷ weighted average shares · filed 2026-04-30 |
| 2023-06-30 | -$1.40 10-Q · filed 2024-08-08 | -$2.58 10-Q · filed 2024-08-08 | -$3.97 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$5.44 derived: net income ÷ weighted average shares · filed 2026-04-30 |
| 2023-03-31 | -$1.17 10-Q · filed 2024-05-09 | -$2.56 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$4.04 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$5.37 derived: net income ÷ weighted average shares · filed 2026-04-30 |
| 2022-12-31 | -$1.40 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$2.88 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$4.21 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$6.16 10-K · filed 2025-02-27 |
| 2022-09-30 | -$1.49 10-Q · filed 2023-11-09 | -$2.82 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$4.78 10-Q · filed 2023-11-09 | -$5.87 derived: net income ÷ weighted average shares · filed 2026-04-30 |
| 2022-06-30 | -$1.33 10-Q · filed 2023-08-03 | -$3.29 10-Q · filed 2023-08-03 | -$4.38 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$5.36 derived: net income ÷ weighted average shares · filed 2026-04-30 |
| 2022-03-31 | -$1.96 10-Q · filed 2023-05-04 | -$3.06 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$4.03 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$5.07 derived: net income ÷ weighted average shares · filed 2026-04-30 |
| 2021-12-31 | -$1.09 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$2.06 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$3.07 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$3.78 10-K · filed 2024-02-22 |
| 2021-09-30 | -$0.97 10-Q · filed 2022-11-03 | -$1.98 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$2.68 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$1.01 10-Q · filed 2022-08-04 | -$1.70 10-Q · filed 2022-08-04 | ||
| 2020-12-31 | -$2.40 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |